Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α. 29463573 2018
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE Mounting evidence indicates that hotspot p53 mutant proteins often possess gain-of-function property in promoting cell mobility and tumor metastasis. 28796261 2018
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE <b>Purpose:</b> TP53 and the TGFβ pathway are major mediators of pancreatic cancer metastasis. 27637888 2018
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 AlteredExpression phenotype BEFREE However, no relationship was observed between MDM2 expression and the risk of distant metastasis (OR = 2.09, 95% CI 1.00-4.36, P = 0.050), and MDM2 was not significantly correlated with TP53 expression (OR 1.22, 95% CI 0.53-2.77, P = 0.643). 25873358 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE New discoveries are made on how frequent and highly penetrant mutations, such as those in the telomerase reverse transcriptase (TERT) and TP53, function in cancer initiation, progression, and metastasis. 27403431 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE BRAF V600E mutation was identified in 1% of patients only. p53 protein was lowly expressed in TGCT metastases compared to the matched primary tumors. 27085458 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 AlteredExpression phenotype BEFREE Moreover, our results revealed that miR-24 expression was significantly increased in HCC metastatic tumor tissues compared with matched non-metastatic tumor tissues, and that the up-regulation of miR-24 was significantly associated with down-regulation of p53 in the HCC tissues. 27780140 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE Whole exome sequencing on the germline, primary and metastatic tumor DNAs, resulted in 27 confirmed mutations, 19 of which (including TP53 mutation) presented in both primary and metastatic lesions. 26474454 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Mutant p53 (mutp53) proteins promote tumor invasion and metastasis in pancreatic ductal adenocarcinoma (PDAC). 28280038 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors. 28028119 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE The aim of the present study was to evaluate the relationship between primary oral cancer and lymph node metastasis in a series of patients with synchronous and metachronous metastases by 2 clonality tests: mt-DNA and TP53 sequence analysis. 25530302 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis. 27045472 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE PIK3CA, SMAD4, and TP53 are most often involved in clonal divergence, providing potential targets that may help guide the clinical management of tumor progression or metastases. 25695693 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE TP53 mutations are usually related with dedifferentiation, progression, and metastasis of thyroid carcinomas. 26260781 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Based on the mutation prevalence in the primary and metastatic sites, we proposed possible clonal evolution patterns marked by functional mutations affecting cancer genes such as KRAS, TP53 and SMAD4 that may play an important role in tumor initiation, progression and metastasis. 26555578 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis. 27012825 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE There were three conditions contributing the extrauterine disease: metastasis from serous endometrial intraepithelial carcinoma (n=10) showed identical TP53 mutation between intrauterine lesions and extrauterine disease, cases of adnexal origin (n=5) had discordant TP53 mutations, and the mixed cellular origin cases (n=6) with both identical and discordant mutation status. 24925054 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE We used in vivo RNAi to target three candidate tumor suppressor genes FOXP1, RYBP and SHQ1, which reside in a frequent deletion on chromosome 3p and show that Shq1 cooperates with Pten and p53 to suppress metastasis. 25592467 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE The primary rectal cancer and the matched metastases (hepatic, pulmonary and lymph nodal) demonstrated no KRAS, NRAS, BRAF and PIK3CA mutations, a microsatellite stable phenotype, and no tumor protein p53 alterations or recurrent copy number alterations on chromosome 8. 26231173 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Using paired isogenic PDX-derived metastatic TNBC cells, loss of p53 promoted tumor growth and consequently increased tumor cell shedding into the blood, thus enhancing metastasis. 26818199 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE TP53 aberrations (n = 3 patients) varied by type and location between primary and metastatic tumors sites but were intra-tumorally conserved. 26727948 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE Our study demonstrated that, across diverse cancers, anomalies in specific tumor suppressor genes (PTEN, CDKN2A, APC, and/or TP53) were independently associated with a worse outcome, as reflected by time to metastases/recurrence, best PFS on treatment, and/or overall survival. 25928476 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE These results suggest that p53 gain-of-function mutations accelerate EC tumor progression and metastasis by interfering with Drosha and p68 binding and pri-miR-26a-1 processing, resulting in reduced miR-26a expression and EZH2 overexpression. 26587974 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation phenotype BEFREE TP53 mutations are furthermore significantly enriched in tumours from patients harbouring metastases. 26647728 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker phenotype BEFREE In the present study, we aimed to investigate the role of del p53 and its association with the proliferation, metastasis and drug resistance of MCF-7 cells. 26572087 2016